Clinical trials

What are clinical trials?

Clinical trials are research studies performed in people that are aimed at evaluating a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment, like a new drug or diet or medical device (for example, a pacemaker) is safe and effective in people. Often a clinical trial is used to learn if a new treatment is more effective and/or has less harmful side effects than the standard treatment.

On this page, we will present the ongoing and future clinical trials and studies, that are still seeking more participants.

Clinical trials and research
  • IQVIA is currently looking for adults (≥18 years of age) who have been diagnosed with narcolepsy or IH currently taking Xywav® to take part in a paid research study. Click here to see if you qualify.
  • DUET Study: The DUET Study will evaluate daytime and nighttime effects of XYWAV® (low-sodium oxybate oral solution), also known as JZP258, in people with idiopathic hypersomnia (IH) or narcolepsy (Type 1 or Type 2). Click here for the brochure. 
  • Jazz Pharmaceuticals and IQVIA are currently looking for individuals (≥18 years of age) who have been diagnosed with NT1, NT2, or IH to take part in a paid research interview study. This research results will help us learn more about what it is like to live with NT1, NT2, or IH, including: impacts on daily life, a better understanding of NT1, NT2, or IH, and how to best measure symptoms and impacts of NT1, NT2, or IH. Click here to enter.
  • The RaiseUp and SunUp Studies are closed. From Takeda Pharmaceuticals.
  • A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy.
    Click here for the US. Click here for Canada. From Axsome Therapeutics.
  • A Study to Evaluate Safety, and Efficacy of SUVN-G3031 in Patients With Narcolepsy With and Without Cataplexy.
    Click here for the US locations. From Mayo Clinic.
  • A study Validation of Pediatric Narcolepsy Patient Reported Outcomes.
    Click here for more information. From Boston Children’s Hospital.
  • Study KP1077.D01 is a clinical trial evaluating the safety and efficacy of KP1077 capsules in adults with idiopathic hypersomnia (IH). Find a study location here. From ZEVRA Therapeutics.
  • A web-based pediatric narcolepsy registry is an organized collection of data focused on health and quality of life information for children under the age of 18 and their caregivers. Click CATNAP® Pediatric Narcolepsy Registry for more information.TM